CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Activities of trusts, funds and similar financial entities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory Filings
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
AGM Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory Filings
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CLAL Biotechnology Industries Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Manages a diversified portfolio of UK micro-cap companies for long-term capital growth.
Guernsey
RMMC
RM INFRASTRUCTURE INCOME PLC Logo
Investment trust in a managed wind-down, realizing its portfolio of UK infrastructure debt.
United Kingdom
RMII
RM Rheiner Management AG Logo
Invests in public companies undergoing special situations like reorganizations and squeeze-outs.
Germany
RMO
ROCKWOOD STRATEGIC PLC Logo
Investment trust unlocking value in undervalued UK small-cap companies through active engagement.
United Kingdom
RKW
Roi Property Fund REIT Logo
A collective investment vehicle investing shareholder funds in a diversified real estate portfolio.
Bulgaria
RPF
Roman DBDR Acquisition Corp. II Logo
A SPAC targeting high-growth TMT firms in Security, AI, and FinTech for a merger.
United States of America
DRDB
Royalty Management Holding Corp Logo
Acquires and monetizes diverse royalty assets in resources, sustainable industry, and digital IP.
United States of America
RMCO
Royalty Pharma plc Logo
Largest buyer of biopharma royalties, providing non-dilutive funding for life sciences.
United States of America
RPRX
ROYCE GLOBAL TRUST, INC. Logo
A closed-end fund investing in global small/mid-cap stocks for long-term capital growth.
United States of America
RGT
ROYCE MICRO-CAP TRUST, INC. Logo
A closed-end fund providing actively managed exposure to undervalued micro-cap stocks for growth.
United States of America
RMT

Talk to a Data Expert

Have a question? We'll get back to you promptly.